Cargando…

Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis

SIMPLE SUMMARY: Although early detection of oral squamous cell carcinoma (OSCC) is considered vital, classical biomarkers have shown poor sensitivity and specificity for early detection and monitoring of OSCC. Therefore, identification of reliable and sensitive biomarkers allowing for early detectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Kodai, Hiyake, Naomi, Hamada, Tomofumi, Yokoyama, Seiya, Mori, Kazuki, Yamashiro, Kouta, Beppu, Mahiro, Sagara, Yasuaki, Sagara, Yoshiaki, Sugiura, Tsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865311/
https://www.ncbi.nlm.nih.gov/pubmed/33504017
http://dx.doi.org/10.3390/cancers13030449
_version_ 1783647816498806784
author Nakamura, Kodai
Hiyake, Naomi
Hamada, Tomofumi
Yokoyama, Seiya
Mori, Kazuki
Yamashiro, Kouta
Beppu, Mahiro
Sagara, Yasuaki
Sagara, Yoshiaki
Sugiura, Tsuyoshi
author_facet Nakamura, Kodai
Hiyake, Naomi
Hamada, Tomofumi
Yokoyama, Seiya
Mori, Kazuki
Yamashiro, Kouta
Beppu, Mahiro
Sagara, Yasuaki
Sagara, Yoshiaki
Sugiura, Tsuyoshi
author_sort Nakamura, Kodai
collection PubMed
description SIMPLE SUMMARY: Although early detection of oral squamous cell carcinoma (OSCC) is considered vital, classical biomarkers have shown poor sensitivity and specificity for early detection and monitoring of OSCC. Therefore, identification of reliable and sensitive biomarkers allowing for early detection and monitoring of OSCC is of the utmost importance. In this study, we successfully identified significantly upregulated or downregulated microRNAs in OSCC patients, and reported that a combination of six microRNAs could distinguish between OSCC and the control group with a higher degree of accuracy. Furthermore, compared with serum squamous cell carcinoma (SCC) antigen, the miRNA panel reflected the presence of OSCC accurately. The present results suggest that the combined microRNA panel based on serum microRNA levels shows potential as a novel diagnostic biomarker of OSCC. ABSTRACT: A lack of reliable biomarkers for oral squamous cell carcinoma (OSCC) poses a major clinical issue. The sensitivity and specificity of classical serum tumor markers, such as the squamous cell carcinoma antigen (SCC-Ag), are quite poor, especially for early detection. This study aimed to identify specific serum miRNAs potentially serving as OSCC biomarkers. The expression levels of candidate miRNAs in serum samples from 40 OSCC patients and 40 healthy controls were quantitatively analyzed via microarray and reverse transcription PCR (RT-PCR) analyses. To enhance the accuracy of detection, we used Fisher’s linear discriminant analysis to establish a diagnostic model that incorporated a combination of selected miRNAs. Consequently, miR-19a and miR-20a were significantly upregulated in the patient group (p = 0.014 and 0.036, respectively), whereas miR-5100 was downregulated (p = 0.001). We found that a combination of six miRNAs (miR-24, miR-20a, miR-122, miR-150, miR-4419a, and miR-5100) could distinguish between OSCC and the control group with a higher degree of accuracy (Area Under the Curve, AUC: 0.844, sensitivity: 55%, and specificity: 92.5%). Furthermore, compared to serum SCC antigen, the 6-miRNA panel could accurately detect the presence of OSCC. The present specific miRNAs panel may serve as a novel candidate biomarker of oral cancer.
format Online
Article
Text
id pubmed-7865311
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78653112021-02-07 Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis Nakamura, Kodai Hiyake, Naomi Hamada, Tomofumi Yokoyama, Seiya Mori, Kazuki Yamashiro, Kouta Beppu, Mahiro Sagara, Yasuaki Sagara, Yoshiaki Sugiura, Tsuyoshi Cancers (Basel) Article SIMPLE SUMMARY: Although early detection of oral squamous cell carcinoma (OSCC) is considered vital, classical biomarkers have shown poor sensitivity and specificity for early detection and monitoring of OSCC. Therefore, identification of reliable and sensitive biomarkers allowing for early detection and monitoring of OSCC is of the utmost importance. In this study, we successfully identified significantly upregulated or downregulated microRNAs in OSCC patients, and reported that a combination of six microRNAs could distinguish between OSCC and the control group with a higher degree of accuracy. Furthermore, compared with serum squamous cell carcinoma (SCC) antigen, the miRNA panel reflected the presence of OSCC accurately. The present results suggest that the combined microRNA panel based on serum microRNA levels shows potential as a novel diagnostic biomarker of OSCC. ABSTRACT: A lack of reliable biomarkers for oral squamous cell carcinoma (OSCC) poses a major clinical issue. The sensitivity and specificity of classical serum tumor markers, such as the squamous cell carcinoma antigen (SCC-Ag), are quite poor, especially for early detection. This study aimed to identify specific serum miRNAs potentially serving as OSCC biomarkers. The expression levels of candidate miRNAs in serum samples from 40 OSCC patients and 40 healthy controls were quantitatively analyzed via microarray and reverse transcription PCR (RT-PCR) analyses. To enhance the accuracy of detection, we used Fisher’s linear discriminant analysis to establish a diagnostic model that incorporated a combination of selected miRNAs. Consequently, miR-19a and miR-20a were significantly upregulated in the patient group (p = 0.014 and 0.036, respectively), whereas miR-5100 was downregulated (p = 0.001). We found that a combination of six miRNAs (miR-24, miR-20a, miR-122, miR-150, miR-4419a, and miR-5100) could distinguish between OSCC and the control group with a higher degree of accuracy (Area Under the Curve, AUC: 0.844, sensitivity: 55%, and specificity: 92.5%). Furthermore, compared to serum SCC antigen, the 6-miRNA panel could accurately detect the presence of OSCC. The present specific miRNAs panel may serve as a novel candidate biomarker of oral cancer. MDPI 2021-01-25 /pmc/articles/PMC7865311/ /pubmed/33504017 http://dx.doi.org/10.3390/cancers13030449 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nakamura, Kodai
Hiyake, Naomi
Hamada, Tomofumi
Yokoyama, Seiya
Mori, Kazuki
Yamashiro, Kouta
Beppu, Mahiro
Sagara, Yasuaki
Sagara, Yoshiaki
Sugiura, Tsuyoshi
Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis
title Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis
title_full Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis
title_fullStr Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis
title_full_unstemmed Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis
title_short Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis
title_sort circulating microrna panel as a potential novel biomarker for oral squamous cell carcinoma diagnosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865311/
https://www.ncbi.nlm.nih.gov/pubmed/33504017
http://dx.doi.org/10.3390/cancers13030449
work_keys_str_mv AT nakamurakodai circulatingmicrornapanelasapotentialnovelbiomarkerfororalsquamouscellcarcinomadiagnosis
AT hiyakenaomi circulatingmicrornapanelasapotentialnovelbiomarkerfororalsquamouscellcarcinomadiagnosis
AT hamadatomofumi circulatingmicrornapanelasapotentialnovelbiomarkerfororalsquamouscellcarcinomadiagnosis
AT yokoyamaseiya circulatingmicrornapanelasapotentialnovelbiomarkerfororalsquamouscellcarcinomadiagnosis
AT morikazuki circulatingmicrornapanelasapotentialnovelbiomarkerfororalsquamouscellcarcinomadiagnosis
AT yamashirokouta circulatingmicrornapanelasapotentialnovelbiomarkerfororalsquamouscellcarcinomadiagnosis
AT beppumahiro circulatingmicrornapanelasapotentialnovelbiomarkerfororalsquamouscellcarcinomadiagnosis
AT sagarayasuaki circulatingmicrornapanelasapotentialnovelbiomarkerfororalsquamouscellcarcinomadiagnosis
AT sagarayoshiaki circulatingmicrornapanelasapotentialnovelbiomarkerfororalsquamouscellcarcinomadiagnosis
AT sugiuratsuyoshi circulatingmicrornapanelasapotentialnovelbiomarkerfororalsquamouscellcarcinomadiagnosis